---
figid: PMC11603874__13046_2024_3218_Fig7_HTML
figtitle: TNFR2 supports BCSC growth and development
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11603874
filename: 13046_2024_3218_Fig7_HTML.jpg
figlink: /pmc/articles/PMC11603874/figure/F7/
number: F7
caption: TNFR2 supports BCSC growth and development. Once TNFR2 is activated via Mb-TNF-α
  or R2TNF, multiple proteins including EGFR, VEGFR2, IL-6/JAK, HER2, and NF-κB are
  activated. EGFR activation leads to ERK1/2 phosphorylation, inducing MNK, xIAP,
  and Snai 2. VEGFR2 activation triggers PI3K/Akt activation, stimulating mTORC, which
  along with IL-6/JAK, HER2, and NF-κB, promotes STAT3 activation. STAT3 induces various
  oncogenic proteins, including Cycline D1, MYC, surviving, VEGF, MMPs, Bcl-XL, IL-6,
  IL-10, and TGF-β. IKKα and IKKβ activation promote HIF-1α, OCT4, CCDC88A, and Akt
  stimulation and the release of NF-κB-p52 to the nucleus and up-regulate TAZ-enhancing
  CYR61 production. HIF-1α will trigger CD47 and SLUG/Jagged1 or SLUG/CD44, while
  Akt stimulates the RAS/RAF/MEK/ERK pathway. These proteins lead to Notch, Hedgehog,
  Wnt, Hippo, SMAD, and PPAR stimulation, promoting BCSC self-renewal, EMT development,
  angiogenesis, and survival. TNFR2, tumor necrosis receptor type 2; Mb-TNF-α, membrane-bound
  tumor necrosis factor; TRAF, TNF receptor associated factor; T2bs-C, TRAF2-binding
  site C; T2bs-N, TRAF2-binding site N; Akt, protein kinase B/serine-threonine kinase;
  mTOR, mammalian (or mechanistic) target of rapamycin; EGFR, epidermal growth factor
  receptor; VEGF, vascular endothelial growth factor; VEGFR2, vascular endothelial
  growth factor receptor 2; EMT, epithelial-mesenchymal; MMPs, matrix metalloproteinases;
  c-MYC, cellular myelocytomatosis; STAT, signal transducer and activator of transcriptions;
  IL-6, interleukin 6; IL-10, interleukin 10; TGF-β, transforming-growth factor β;
  HIF-1α, hypoxia inducible factor 1 alpha; IKKs, IκB kinases; Bcl-2, B cell lymphoma
  2; HER2, human epidermal growth factor receptor 2; PI3K, phosphoinositide 3-kinases;
  ERK, extracellular signal-regulated kinase; MNK, MAPK interacting kinase; PPAR,
  peroxisome proliferator-activated receptor
papertitle: Understanding the role of TNFR2 signaling in the tumor microenvironment
  of breast cancer
reftext: Ali Mussa, et al. J Exp Clin Cancer Res. 2024;43(NA).
year: '2024'
doi: 10.1186/s13046-024-03218-1
journal_title: 'Journal of Experimental & Clinical Cancer Research : CR'
journal_nlm_ta: J Exp Clin Cancer Res
publisher_name: BMC
keywords: Immune checkpoint | Immunosuppressive TME | TNF | TNFRSF1B | CD120b
automl_pathway: 0.7888377
figid_alias: PMC11603874__F7
figtype: Figure
redirect_from: /figures/PMC11603874__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11603874__13046_2024_3218_Fig7_HTML.html
  '@type': Dataset
  description: TNFR2 supports BCSC growth and development. Once TNFR2 is activated
    via Mb-TNF-α or R2TNF, multiple proteins including EGFR, VEGFR2, IL-6/JAK, HER2,
    and NF-κB are activated. EGFR activation leads to ERK1/2 phosphorylation, inducing
    MNK, xIAP, and Snai 2. VEGFR2 activation triggers PI3K/Akt activation, stimulating
    mTORC, which along with IL-6/JAK, HER2, and NF-κB, promotes STAT3 activation.
    STAT3 induces various oncogenic proteins, including Cycline D1, MYC, surviving,
    VEGF, MMPs, Bcl-XL, IL-6, IL-10, and TGF-β. IKKα and IKKβ activation promote HIF-1α,
    OCT4, CCDC88A, and Akt stimulation and the release of NF-κB-p52 to the nucleus
    and up-regulate TAZ-enhancing CYR61 production. HIF-1α will trigger CD47 and SLUG/Jagged1
    or SLUG/CD44, while Akt stimulates the RAS/RAF/MEK/ERK pathway. These proteins
    lead to Notch, Hedgehog, Wnt, Hippo, SMAD, and PPAR stimulation, promoting BCSC
    self-renewal, EMT development, angiogenesis, and survival. TNFR2, tumor necrosis
    receptor type 2; Mb-TNF-α, membrane-bound tumor necrosis factor; TRAF, TNF receptor
    associated factor; T2bs-C, TRAF2-binding site C; T2bs-N, TRAF2-binding site N;
    Akt, protein kinase B/serine-threonine kinase; mTOR, mammalian (or mechanistic)
    target of rapamycin; EGFR, epidermal growth factor receptor; VEGF, vascular endothelial
    growth factor; VEGFR2, vascular endothelial growth factor receptor 2; EMT, epithelial-mesenchymal;
    MMPs, matrix metalloproteinases; c-MYC, cellular myelocytomatosis; STAT, signal
    transducer and activator of transcriptions; IL-6, interleukin 6; IL-10, interleukin
    10; TGF-β, transforming-growth factor β; HIF-1α, hypoxia inducible factor 1 alpha;
    IKKs, IκB kinases; Bcl-2, B cell lymphoma 2; HER2, human epidermal growth factor
    receptor 2; PI3K, phosphoinositide 3-kinases; ERK, extracellular signal-regulated
    kinase; MNK, MAPK interacting kinase; PPAR, peroxisome proliferator-activated
    receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF1B
  - MAPK3
  - MAPK1
  - EGFR
  - ERBB2
  - KDR
  - IL6
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ATP7A
  - XIAP
  - AKT1
  - AKT2
  - AKT3
  - SNAI2
  - SOX2
  - TRAF2
  - TANK
  - NFKB1
  - IKBKB
  - STAT3
  - CCDC88A
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - CD47
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - HIF1A
  - CD44
  - PPARA
  - PPARD
  - PPARG
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CCN1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - DHH
  - IHH
  - SHH
  - TAFAZZIN
  - WWTR1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - MYC
  - IL10
  - TGFB1
  - TGFB2
  - TGFB3
  - Nucleus
---
